ELI LILLY
ELI LILLY
- EUR (-)
- 15-min zeitverzögert - Deutschland Aktien
Eröffnung: -
Veränderung: -
Volumen: -
Tief: -
Hoch: -
Hoch - Tief: -
Typ: Aktien
Ticker: LLY
ISIN:

Thinking about trading options or stock in Monday.Com, Boeing, Eli Lilly, Xpeng, or Genmab?

  • 69
Thinking about trading options or stock in Monday.Com, Boeing, Eli Lilly, Xpeng, or Genmab?

PR Newswire

NEW YORK, Nov. 13, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MNDY, BA, LLY, XPEV, and GMAB.

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

  1. MNDY: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=MNDY&prnumber=111320231
  2. BA: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=BA&prnumber=111320231
  3. LLY: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=LLY&prnumber=111320231
  4. XPEV: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=XPEV&prnumber=111320231
  5. GMAB: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=GMAB&prnumber=111320231

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-mondaycom-boeing-eli-lilly-xpeng-or-genmab-301986074.html

SOURCE InvestorsObserver

PR Newswire
PR Newswire